Navigation Links
The Lancet: New trial suggests cheaper drugs for common heart attack procedure could improve outcomes and save health budgets millions
Date:7/4/2014

A new study published in The Lancet compares outcomes for two drugs used to prevent blood clot formation during emergency heart attack treatment. The study suggests that use of one of the drugs, heparin, could result in improved outcomes (such as a reduced rate of repeat heart attacks), compared to the other drug tested, bivalirudin, which is in widespread use in high-income countries, and is around 400 times more expensive than heparin.

The results of the HEAT-PPCI trial suggest that systematic use of heparin rather than bivalirudin after primary percutaneous coronary intervention (PPCI) the most commonly used treatment for heart attack, which unblocks the arteries carrying blood to the heart could save health services substantial sums of money, at the same time as potentially improving patient outcomes.

Patients who undergo PPCI usually receive a combination of antithrombotic drugs to prevent any further blood clots forming during the procedure and after it has been completed. The most commonly used antithrombotic drugs are unfractionated heparin and bivalirudin, and although several previous trials have compared the two drugs, the evidence is unclear as to which drug results in better outcomes.

The trial took place at the Liverpool Heart and Chest Hospital in the UK, where 1829 patients undergoing emergency angiography (an x-ray examination of the heart's arteries after a suspected heart attack) were recruited to the trial. More than four fifths of these patients then went on to receive PPCI; approximately half received heparin, and half received bivalirudin. Researchers then recorded how many patients in both groups experienced a major adverse cardiac event, such as death or another heart attack, within 28 days after surgery.

The results show that overall rates of major adverse cardiac events were significantly lower in the group who received heparin, although the rates of adverse events were low, as expected, in both groups
'/>"/>

Contact: Matthew Back
matthew.back@lhch.nhs.uk
44-015-160-01423
The Lancet
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. The Lancet: Midwifery matters more than ever
2. The Lancet: UK has one of the highest death rates for children in western Europe
3. The Lancet: China halves tuberculosis prevalence in just 20 years
4. First evidence for painless atrial fibrillation treatment
5. ASPIRE Phase III trial of vaginal ring to prevent HIV completes enrollment of 2,629 women
6. GW leads clinical trial to reduce epileptic seizures in people with temporal lobe epilepsy
7. First first patient enrolled in PROSPECT II clinical trial
8. New definition of kidney disease for clinical trials could lead to new treatments
9. Trial uncovers potential dangers of chemotherapy regimen for bladder cancer patients
10. UH part of $7.5M NIH clinical trial on nearsightedness in children
11. Experimental trial represents promising step toward universal antidote for snakebite
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... 23, 2014 Every year AlignLife clinics ... AlignLife experience rapid growth in the Greenville, SC area ... opportunity. AlignLife of Simpsonville will be partnering ... their first annual Toy Drive. These six offices came ... support with this year's toy drive. With so many ...
(Date:11/22/2014)... PrettyTailor , an outstanding dress company, has recently updated ... buy new dresses at its online shop now. For ... As a matter of fact, PrettyTailor specializes in beautiful ... types of wedding outfits, including bridesmaid dresses, mother of ... provides a variety of occasion dresses, such as cocktail ...
(Date:11/22/2014)... 2014 Recently, Locks-Magnetic.com , one ... new promotion of mag locks for glass doors online. ... discount on these fresh products. Customers can get more ... glass doors are in excellent performance. Customers who want ... as soon as possible. They also can enjoy ...
(Date:11/22/2014)... 22, 2014 Setria® Glutathione is ... approved it for use “as a therapeutically active ... within the Therapeutic Goods (Listing) Notice 2014 (No. ... Hakko’s Setria® Glutathione will be exclusivity distributed in ... sources and imports fine chemicals to Australian manufacturers. ...
(Date:11/22/2014)... In order to provide better services, LunaDress has ... dresses. The business knows that a suitable cocktail party dress ... , Now, the party dresses supplier’s high quality items are ... leading company in fashion industry, LunaDress understands that it is ... So it always raises the professional level and innovation ability. ...
Breaking Medicine News(10 mins):Health News:Greenville Area AlignLife Offices Join Together for a Local Toy Drive 2Health News:Customers Are Welcome to Shop at PrettyTailor.com 2Health News:Discounted Mag Locks for Glass Doors Revealed by Locks-Magnetic.com 2Health News:Setria® Glutathione Now Available in Australia 2Health News:Setria® Glutathione Now Available in Australia 3Health News:LunaDress Unveils Fabulous Cocktail Party Dresses 2
... than can strike younger adults , , WEDNESDAY, March 11 ... test for quick diagnosis of a rare but potentially ... sudden death in young people. , The disease is ... flaw causes the muscle cells of one of the ...
... Stigmatize a Health FoodSAN FRANCISCO, March 11 Today ... verdict in a 2006 case which established that the ... occurring, and too insignificant to require warning labels. A ... Deputy Attorney General Sue Fiering argued that the labels ...
... HOUSTON, March 11 Salmonella bacteria research ... key elements of the bacteria,s disease-causing potential ... fight food-borne infections on Earth.(Logo: ... of food poisoning and related illnesses. According ...
... of Your Diabetes (TCOYD) conference and health fair will ... Center, bringing national and local medical experts in diabetes ... at risk for diabetes, and their loved ones for ... will discuss practical advice and developments in the treatment ...
... of the flu shot across the nation, has announced the availability ... ... 11, 2009-- Nationwide Medical/Surgical, a leading provider of the flu shot ... flu vaccine ., , ,The influenza virus, more commonly known as ...
... Grammy Award-winning singer advocates for research into disease ... Award-winning artist LeAnn Rimes shared her personal story ... psoriasis, and she encouraged lawmakers to support much-needed ... autoimmune disease."I was first diagnosed with psoriasis at ...
Cached Medicine News:Health News:New Test Seems to Spot Deadly Heart Condition 2Health News:New Test Seems to Spot Deadly Heart Condition 3Health News:Consumers Win Major Victory Over Seafood Scaremongers 2Health News:Space Research May Help Explain Salmonella Illness 2Health News:Space Research May Help Explain Salmonella Illness 3Health News:Taking Control of Your Diabetes Conference Returns to Hawaii to Bring Answers, Advocacy and Hope for People with Diabetes 2Health News:Nationwide Medical/Surgical Announces Preservative Free Flu Vaccine Available 2Health News:LeAnn Rimes Shares Her Personal Struggle With Psoriasis in Nation's Capital 2Health News:LeAnn Rimes Shares Her Personal Struggle With Psoriasis in Nation's Capital 3Health News:LeAnn Rimes Shares Her Personal Struggle With Psoriasis in Nation's Capital 4
(Date:11/22/2014)... 21, 2014  Particle Sciences, Inc (PSI), the ... and manufactured a new innovative vaginal ring for ... Development arm of Exeltis Pharmaceuticals.  According to ... at Particle Sciences, "This vaginal ring was developed ... sciences and modeling expertise.  We are thrilled it ...
(Date:11/21/2014)... PARK, Md. , Nov. 21, 2014  The ... today will host the ceremonial groundbreaking of the new ... College Park. The new building will cultivate transformative new ... health.  Taking place at 10:00 a.m. on ... in the Paint Branch Parking Lot, adjacent to the ...
(Date:11/21/2014)... 2014   Rock Creek Pharmaceuticals, Inc., (NASDAQ: ... scheduled to present at the Biotech Showcase™ 2015 taking ... on January 12-14, 2015. Michael ... Creek Pharmaceuticals, will present preclinical and clinical data for ... anti-inflammatory pharmacological characteristics. Dr. Mullan will outline the Company,s ...
Breaking Medicine Technology:Particle Sciences' Clinical Trial Supplies Group Manufactures Innovative Vaginal Ring 2University of Maryland Breaks Ground for A. James Clark Hall 2University of Maryland Breaks Ground for A. James Clark Hall 3University of Maryland Breaks Ground for A. James Clark Hall 4Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 2Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 3Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 4